ObjectiveTo study the cause of different prognosis in typical medullary carcinoma and atypical medullary carcinoma. MethodsThe immunohistochemical staining method was used to evaluate the positivity of Ecadherin,βcatenin, in 30 cases of atypical medullary carcinoma and 18 cases of typical medullary carcinoma and 10 cases of normal breast. ResultsThe positive rate and staining intensity of Ecadherin and βcatenin oncoprotein were significantly higher in typical medullary carcinoma than in atypical medullary carcinoma(P lt;0.01).ConclusionExpression of Ecadherin and βcatenin is one of the causes of similar morphology and different prognosis in medullary breast carcinoma.
Citation：
LI Xiaoming,WEN Lichao,ZHU Renzhi.. Study the Different Biology Behavior of Typical Breast Medullary Carcinoma and Atypical Medullary Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2003, 10(3): 268-269. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
Ridolfi RL, Rosen PP, Port A, et al. Medullary carcinoma of the breast: a clinicopathologic study with 10 year followup[J]. Cancer, 1977; 40（4）∶1365.
|
| 2. |
Rapin V, Contesso G, Mouriesse H, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma[J]. Cancer, 1988； 61（12）∶2503.
|
| 3. |
Charpin C, Bonnier P, Garcia S, et al. Ecadherin and betacatenin expression in breast medullary carcinomas[J]. Int J Oncol, 1999; 15(2)∶285.
|
| 4. |
Grabsch H, Takeno S, Noguchi T， et al. Different patterns of betacatenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome [J]. Histopathology， 2001; 39(2)∶141.
|
- 1. Ridolfi RL, Rosen PP, Port A, et al. Medullary carcinoma of the breast: a clinicopathologic study with 10 year followup[J]. Cancer, 1977; 40（4）∶1365.
- 2. Rapin V, Contesso G, Mouriesse H, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma[J]. Cancer, 1988； 61（12）∶2503.
- 3. Charpin C, Bonnier P, Garcia S, et al. Ecadherin and betacatenin expression in breast medullary carcinomas[J]. Int J Oncol, 1999; 15(2)∶285.
- 4. Grabsch H, Takeno S, Noguchi T， et al. Different patterns of betacatenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome [J]. Histopathology， 2001; 39(2)∶141.
